INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 24 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | -98.5% | 1,000 | -98.4% | 0.00% | – |
| Q3 2019 | $68,000 | -19.0% | 63,807 | -12.1% | 0.00% | – |
| Q2 2019 | $84,000 | -37.8% | 72,562 | +3.9% | 0.00% | – |
| Q1 2019 | $135,000 | -41.0% | 69,848 | -29.7% | 0.00% | – |
| Q4 2018 | $229,000 | -62.1% | 99,359 | +12.4% | 0.00% | – |
| Q3 2018 | $604,000 | -52.3% | 88,368 | +64.4% | 0.00% | – |
| Q2 2018 | $1,267,000 | +481.2% | 53,740 | +576.3% | 0.00% | – |
| Q1 2018 | $218,000 | – | 7,946 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |